课题基金 / 基金详情

Development of strategy to treat allergic diseases via targeting surface molecules on lymphocytes and intracellular signaling molecules

Development of strategy to treat allergic diseases via targeting surface molecules on lymphocytes and intracellular signaling molecules
通过靶向淋巴细胞表面分子和细胞内信号分子开发治疗过敏性疾病的策略
批准号:
20390282
负责人:
OKUMURA Ko
金额:
$11.9万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

OKUMURA Ko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Members of the T-cell immunoglobulin mucin (Tim) family control a variety of immune responses including Th1 and Th2 differentiation of T cells. We found that TIM-3 was expressed on C8+ dendritic cells (DC) and TIM-3 was crucial for clearance of apoptotic cells by phagocytes. Moreover, TIM-3-dependent phagocytosis of apoptotic cells was crucial for cross-presentation of dying cell-associated antigens. On the other hand, TIM-2 was found to be expressed on B cells and induced positive signals into B cells. Therefore, administration of agonistic anti-TIM-2 antibody significantly exacerbated type II collagen-induced arthritis. We next investigated a role for autophagy in the development and function of mast cells. We found that conversion of type I to type II light chain (LC3)-II, a hallmark of autophagy, was constitutively induced in mast cells under full nutrient conditions, and LC3-II localized in secretory granules of mast cells. Although deletion of Atg7 did not impair the development of BMMCs, Atg7(-/-) BMMCs showed severe impairment of degranulation, but not cytokine production upon antigen stimulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.4049/jimmunol.182.1.250
发表时间: 2009-01-01
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Kawamura T, Takeda K, Kaneda H, Matsumoto H, Hayakawa Y, Raulet DH, Ikarashi Y, Kronenberg M, Yagita H, Kinoshita K, Abo T, Okumura K, Smyth MJ]
通讯作者: Smyth MJ
RANK-RANKL signaling pathway is critically in volvedin the function of CD4+CD25+ regulatory T cells in chronic colitis.
RANK-RANKL信号通路在慢性结肠炎中关键参与CD4 CD25调节性T细胞的功能。
DOI: --
发表时间: 2009
期刊: J. Immunol. 182
影响因子: --
作者: [Totsuka T, Okamoto R, Nakamura T, Watanabe M(他8名、5番目)]
通讯作者: Watanabe M(他8名、5番目)
DOI: 10.1053/j.gastro.2010.07.003
发表时间: 2010-12
期刊: Gastroenterology
影响因子: 29.4
作者: [Uchida Y, Ke B, Freitas MC, Yagita H, Akiba H, Busuttil RW, Najafian N, Kupiec-Weglinski JW]
通讯作者: Kupiec-Weglinski JW
NF-κB2(p100)limits TNF-alpha-induced osteoclastogenesis
NF-κB2(p100)限制TNF-α诱导的破骨细胞生成
DOI: --
发表时间: 2009
期刊: J Clin Invest 119
影响因子: --
作者: [Tanaka, S., Nakano, H.]
通讯作者: H.
92
    Development of the antibody medical treatment to autoimmune and asthmatic diseases based on new target molecule.
    • 批准号:
      23390260
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2011
    • 负责人:
      OKUMURA Ko
    • 依托单位:
    Studies on wetting and fracture based on the spirit of impressionistic physics
    • 批准号:
      20340110
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.74万
    • 财政年份:
      2008
    • 负责人:
      OKUMURA Ko
    • 依托单位:
    Statistical analyses of allergy-related polymorphisms
    • 批准号:
      07F07462
    • 项目类别:
      Grant-in-Aid for JSPS Fellows
    • 资助金额:
      $1.47万
    • 财政年份:
      2007
    • 负责人:
      OKUMURA Ko
    • 依托单位:
    Functional analysis of costimulatory molecules for autoimmune diseases
    • 批准号:
      18390292
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.21万
    • 财政年份:
      2006
    • 负责人:
      OKUMURA Ko
    • 依托单位:
    海外基金